JP2001517206A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001517206A5 JP2001517206A5 JP1998509732A JP50973298A JP2001517206A5 JP 2001517206 A5 JP2001517206 A5 JP 2001517206A5 JP 1998509732 A JP1998509732 A JP 1998509732A JP 50973298 A JP50973298 A JP 50973298A JP 2001517206 A5 JP2001517206 A5 JP 2001517206A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2409896P | 1996-08-16 | 1996-08-16 | |
| US60/024,098 | 1996-08-16 | ||
| PCT/US1997/012868 WO1998006746A2 (en) | 1996-08-16 | 1997-08-04 | Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007284431A Division JP2008044969A (ja) | 1996-08-16 | 2007-10-31 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001517206A JP2001517206A (ja) | 2001-10-02 |
| JP2001517206A5 true JP2001517206A5 (https=) | 2005-04-07 |
Family
ID=21818860
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50973298A Withdrawn JP2001517206A (ja) | 1996-08-16 | 1997-08-04 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
| JP2007284431A Withdrawn JP2008044969A (ja) | 1996-08-16 | 2007-10-31 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
| JP2011168822A Withdrawn JP2012001548A (ja) | 1996-08-16 | 2011-08-01 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
| JP2013218131A Withdrawn JP2014012738A (ja) | 1996-08-16 | 2013-10-21 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
| JP2016043177A Pending JP2016106137A (ja) | 1996-08-16 | 2016-03-07 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007284431A Withdrawn JP2008044969A (ja) | 1996-08-16 | 2007-10-31 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
| JP2011168822A Withdrawn JP2012001548A (ja) | 1996-08-16 | 2011-08-01 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
| JP2013218131A Withdrawn JP2014012738A (ja) | 1996-08-16 | 2013-10-21 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
| JP2016043177A Pending JP2016106137A (ja) | 1996-08-16 | 2016-03-07 | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6187306B1 (https=) |
| EP (1) | EP0929318B1 (https=) |
| JP (5) | JP2001517206A (https=) |
| AT (1) | ATE283069T1 (https=) |
| AU (1) | AU3889997A (https=) |
| CA (1) | CA2263503C (https=) |
| DE (1) | DE69731756T2 (https=) |
| WO (1) | WO1998006746A2 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096313A (en) * | 1996-02-09 | 2000-08-01 | Ludwig Institute For Cancer Research | Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant |
| US6277368B1 (en) | 1996-07-25 | 2001-08-21 | The Regents Of The University Of California | Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine |
| US5891432A (en) * | 1997-07-29 | 1999-04-06 | The Immune Response Corporation | Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same |
| JP2002506980A (ja) * | 1998-03-20 | 2002-03-05 | ジェンザイム・コーポレーション | 新規の相補的レセプター−リガンド対およびそれを使用する養子免疫療法 |
| GB9810040D0 (en) * | 1998-05-11 | 1998-07-08 | Univ Nottingham | Blood borne tumour markers |
| US6316420B1 (en) * | 1998-07-28 | 2001-11-13 | Technion Research And Development Foundation Ltd. | DNA cytokine vaccines and use of same for protective immunity against multiple sclerosis |
| GB9827228D0 (en) * | 1998-12-10 | 1999-02-03 | Univ Nottingham | Cancer detection method and reagents |
| DE19905501B4 (de) | 1999-02-10 | 2005-05-19 | MediGene AG, Gesellschaft für molekularbiologische Kardiologie und Onkologie | Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels |
| US20030232399A1 (en) * | 2000-06-14 | 2003-12-18 | Robertson John Forsyth Russell | Cancer detection methods and reagents |
| WO2001098464A2 (en) * | 2000-06-22 | 2001-12-27 | Aventis Pasteur Limited | Continuous adherent melanocyte cell line |
| US20050201993A1 (en) * | 2002-10-09 | 2005-09-15 | Link Charles J.Jr. | Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| DK1549353T3 (da) * | 2002-10-09 | 2010-07-12 | Central Iowa Health System | Anvendelse af alfa(1,3)galactosyltransferaseudtrykkende allogene tumorceller til vaccination mod tumorer |
| GB2424273B (en) * | 2002-11-14 | 2007-06-27 | Univ Nottingham | Method for preparing tumour marker protein |
| WO2005017149A1 (en) * | 2003-06-03 | 2005-02-24 | Cell Genesys, Inc. | Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| US20050136035A1 (en) * | 2003-06-03 | 2005-06-23 | Derek Ko | Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site |
| US20050186178A1 (en) * | 2003-08-28 | 2005-08-25 | Ennist David L. | Oncolytic adenoviral vectors encoding GM-CSF |
| SI1889059T1 (sl) | 2005-05-27 | 2009-12-31 | Oncimmune Ltd | Izboljšani imunotestni postopek |
| GB2426581A (en) * | 2005-05-27 | 2006-11-29 | Univ Nottingham | Immunoassay methods |
| JP6092497B2 (ja) | 2006-03-30 | 2017-03-08 | ユニバーシティー オブ カリフォルニア | 抗ｃｔｌａ−４抗体の限局性分泌のための方法および組成物 |
| US7919079B2 (en) | 2006-03-31 | 2011-04-05 | Biosante Pharmaceuticals, Inc. | Cancer immunotherapy compositions and methods of use |
| US8574848B2 (en) | 2006-09-13 | 2013-11-05 | Oncimmune Ltd. | Immunoassay methods |
| US7998486B2 (en) | 2006-10-25 | 2011-08-16 | Newlink Genetics Corporation | Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes |
| AR060424A1 (es) * | 2007-04-11 | 2008-06-18 | Consejo Nac Invest Cient Tec | Lineas celulares , composiciones para el tratamiento de melanomas que las comprenden procedimientos para preparar las composiciones y metodos de tratamiento |
| GB0725239D0 (en) * | 2007-12-24 | 2008-02-06 | Oncimmune Ltd | Calibrator for autoantibody assay |
| WO2011049246A1 (ja) * | 2009-10-23 | 2011-04-28 | 東レ・ダウコーニング株式会社 | 新規オルガノポリシロキサン共重合体 |
| GB2592821B (en) | 2015-07-31 | 2022-01-12 | Univ Minnesota | Modified cells and methods of therapy |
| JP7181862B2 (ja) | 2016-10-18 | 2022-12-01 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | 腫瘍浸潤リンパ球および治療の方法 |
| KR20240024328A (ko) | 2016-11-22 | 2024-02-23 | 알로플렉스 바이오테라퓨틱스 | 동종이형 종양 세포 백신 |
| WO2019006418A2 (en) | 2017-06-30 | 2019-01-03 | Intima Bioscience, Inc. | ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4595653A (en) | 1981-06-09 | 1986-06-17 | Lee Biomolecular Research Laboratories, Inc. | Process for assaying cellular immunity |
| US5045320A (en) | 1989-03-23 | 1991-09-03 | Medical Biology Institute | Large multivalent immunogen |
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| DE69114299T3 (de) | 1990-09-14 | 2005-09-15 | The Johns Hopkins University | Verfahren und zusammensetzungen für gentherapie und stärkung des immunsystems. |
| US5342774A (en) | 1991-05-23 | 1994-08-30 | Ludwig Institute For Cancer Research | Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 |
| EP1216710B1 (en) * | 1991-10-04 | 2006-04-05 | Whitehead Institute For Biomedical Research | Regulation of systemic immune responses utilizing cytokines and antigens |
| US5637483A (en) * | 1991-10-04 | 1997-06-10 | Whitehead Institute For Biomedical Research | Irradiated tumor cell vaccine engineered to express GM-CSF |
| ATE272113T1 (de) * | 1994-02-16 | 2004-08-15 | Crucell Holland Bv | Melanoma-assoziierte antigene, epitope davon und impstoffe gegen melanoma |
| AU706443B2 (en) * | 1994-04-22 | 1999-06-17 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Melanoma antigens |
| US5759535A (en) * | 1994-05-13 | 1998-06-02 | Research Corporation Technologies, Inc. | Immunotherapeutic strategies for the treatment of cancer |
-
1997
- 1997-08-04 JP JP50973298A patent/JP2001517206A/ja not_active Withdrawn
- 1997-08-04 AT AT97936164T patent/ATE283069T1/de not_active IP Right Cessation
- 1997-08-04 CA CA2263503A patent/CA2263503C/en not_active Expired - Lifetime
- 1997-08-04 WO PCT/US1997/012868 patent/WO1998006746A2/en not_active Ceased
- 1997-08-04 DE DE69731756T patent/DE69731756T2/de not_active Expired - Lifetime
- 1997-08-04 AU AU38899/97A patent/AU3889997A/en not_active Abandoned
- 1997-08-04 EP EP97936164A patent/EP0929318B1/en not_active Expired - Lifetime
- 1997-08-05 US US08/906,029 patent/US6187306B1/en not_active Expired - Lifetime
-
2007
- 2007-10-31 JP JP2007284431A patent/JP2008044969A/ja not_active Withdrawn
-
2011
- 2011-08-01 JP JP2011168822A patent/JP2012001548A/ja not_active Withdrawn
-
2013
- 2013-10-21 JP JP2013218131A patent/JP2014012738A/ja not_active Withdrawn
-
2016
- 2016-03-07 JP JP2016043177A patent/JP2016106137A/ja active Pending